➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Moodys
Harvard Business School
Medtronic
Express Scripts

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Plinabulin

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Plinabulin?

Plinabulin is an investigational drug.

There have been 8 clinical trials for Plinabulin. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2016.

The most common disease conditions in clinical trials are Neutropenia, Lung Neoplasms, and Carcinoma, Non-Small-Cell Lung. The leading clinical trial sponsors are BeyondSpring Pharmaceuticals Inc., National Cancer Institute (NCI), and Lyudmila Bazhenova, M.D.

There are fifteen US patents protecting this investigational drug and ninety-one international patents.

Recent Clinical Trials for Plinabulin
TitleSponsorPhase
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung CancerJyoti MalhotraPhase 1/Phase 2
Plinabulin iv Solution in Prevention of TAC Induced NeutropeniaBeyondSpring Pharmaceuticals Inc.Phase 2
Plinabulin vs. Pegfilgrastim in Reducing the Duration of Severe Neutropenia in Breast Cancer Patients Receiving Myelosuppressive Chemotherapy With Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)BeyondSpring Pharmaceuticals Inc.Phase 2/Phase 3

See all Plinabulin clinical trials

Clinical Trial Summary for Plinabulin

Top disease conditions for Plinabulin
Top clinical trial sponsors for Plinabulin

See all Plinabulin clinical trials

US Patents for Plinabulin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Plinabulin   Start Trial Method of treating a brain tumor BeyondSpring Pharmaceuticals, Inc. (New York, NY)   Start Trial
Plinabulin   Start Trial Plinabulin compositions BeyondSpring Pharmaceuticals, Inc. (New York, NY)   Start Trial
Plinabulin   Start Trial Method of treating cancer associated with a RAS mutation BeyondSpring Pharmaceuticals, Inc. (New York, NY)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Moodys
Harvard Business School
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.